New blood tests could help monitor Flare-Ups in kids with arthritis
NCT ID NCT07356804
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study measured two newer blood markers (calprotectin and serum amyloid protein) alongside standard tests in 20 children with juvenile arthritis and related conditions. The goal was to see if these markers could better track disease flare-ups in everyday clinic visits. The study did not test any treatment, only observed changes over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOINFLAMMATORY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Santa Creu i Sant Pau Hospital
Barcelona, Catalonia, 08025, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a biologic drug tame juvenile arthritis in kids?
- Genetic hunt for hidden causes of mysterious inflammatory diseases
- Simple core workouts may tame pain and fatigue in kids with arthritis
- Hidden muscle loss in young arthritis patients under the microscope
- Can a quick quiz replace gym tests for kids with chronic illness?
- Herbal hope: propolis and green tea may beat standard care for root canal pain